關鍵數據
4.860今開
5.215最高
388.08K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.27%換手率
4.830昨收
4.860最低
1.97M成交額
虧損本益比靜
2.94市淨率
0.00%股息率 TTM
-18.10%ROA
5.43052週最高
104.30量比
-62.03M淨利潤
145.86M總股本
-0.4578每股盈餘TTM
0.36Beta
-20.25%ROE
1.35052週最低
8.59%振幅
58.95%毛利率
733.68M總市值
14.67回報/風險
4.79%風險率

即將為您帶來更多新聞,敬請期待。 。 。
OmniAb Inc評分
0.08與上次評分對比預測8.57
財務診斷7.07
技術分析4.35
公司估值6.97
機構認同度5.00
風險評估4.04
分析師評級
OmniAb Inc 最新財報電話會記錄
OmniAb (OABI) 2026 年第三季法說會:上調營收指引
OmniAb 2026 年第三季財報電話會議:營收增至 400 萬美元,2026 年財測指引上調至 3,500 萬至 3,900 萬美元,且 xPloration 的成長仍是核心焦點。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
OmniAb Inc 簡介
OmniAb, Inc. licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
行業生物技術與醫療研究
公司代碼OABI
員工數量114
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Avista Capital Holdings, LP | 10.94% |
|---|
| Whitefort Capital Management, LP | 9.81% |
|---|
| Ash X LP | 5.21% |
|---|
| BlackRock Institutional Trust Company, N.A. | 5.10% |
|---|
| 股東類型 | 佔比 |
|---|
| Hedge Fund | 16.14% |
|---|
| Investment Advisor | 14.43% |
|---|
| Private Equity | 10.94% |
|---|
| Investment Advisor/Hedge Fund | 8.67% |
|---|
常見問題
OmniAb Inc(OABI)的當前股價是多少?
OmniAb Inc(OABI)的當前股價是 5.03。
OmniAb Inc股票的52週最高點是5.43。
OmniAb Inc股票的52週最低點是1.35。
現在OmniAb Inc(OABI)的股票是買入、持有還是賣出?
根據分析師評級,OmniAb Inc(OABI)的總體評級為買入,目標價格為8.33。
OmniAb Inc(OABI)股票的每股收益(EPS TTM)是多少
OmniAb Inc(OABI)股票的每股收益(EPS TTM)是-0.46。